BAYER CROPSCIENCE LTD.

Bayer CropScience Ltd. has announced the closure of its trading window for all designated persons. This closure will commence on October 01, 2026, and will remain in effect until the declaration of the company's quarterly financial results for the quarter ended September 30, 2026, plus an additional two days thereafter. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal policy.

Bayer CropScience Ltd has been assigned an ESG Rating of "Crisil ESG 66" and a Core ESG rating of "Crisil Core ESG 70" by Crisil ESG Ratings and Analytics Limited. The ratings are based on publicly available disclosures and information. Notably, Crisil independently prepared this report without engagement from the company. The ratings reflect the company's performance on Environmental, Social, and Governance parameters. This information is also available on the company's website.

Bayer CropScience Ltd announced its unaudited financial results for the quarter ended June 30, 2026, following a Board of Directors meeting held on August 05, 2026. The results were prepared in accordance with Indian Accounting Standard 34 and reviewed by statutory auditors Deloitte Haskins & Sells LLP. The company confirmed that the accompanying financial statement contains no material misstatements.

Bayer CropScience Limited announced the outcome of its Board Meeting held on August 05, 2026. The Board of Directors approved the Unaudited Financial Results for the quarter ended June 30, 2026. The financial results were accompanied by a Limited Review Report from the Statutory Auditors, Deloitte Haskins & Sells LLP. The meeting commenced at 04:30 p.m. (IST) and concluded at 05:00 p.m. (IST).

Bayer CropScience Limited announced its unaudited financial results for the first quarter of FY 2026-27, ending June 30, 2026. Revenue from operations stood at ₹18,350 million, a 4% decrease year-on-year. However, Profit Before Tax saw a significant increase of 20% year-on-year, reaching ₹4,021 million. Profit After Tax grew by 15%, aided by improved gross margins and a ₹639 million income from the divestment of marketing rights for formulated products. The company cited challenging weather and evolving market conditions as factors influencing performance, while emphasizing a focus on channel management and innovation.

Bayer CropScience Limited announced its unaudited financial results for the first quarter of FY 2026-27, ending June 30, 2026. Revenue from operations stood at ₹18,350 million, a 4% decrease year-on-year. However, Profit Before Tax saw a significant increase of 20% to ₹4,021 million. Profit After Tax rose by 15%, aided by improved gross margins and a ₹639 million income from the divestment of marketing rights for formulated products. The company cited challenging weather and evolving market conditions, including potential El Niño impacts, as factors influencing performance. Management remains focused on channel management, innovation, and sustainable value creation for farmers.

Bayer CropScience Ltd announced significant board changes following a meeting on August 5, 2026. Mr. Pankaj Ramanbhai Patel will complete his second term as Chairman and Non-Executive Independent Director on September 11, 2026, stepping down from his roles including chairmanship of the Audit Committee and CSR Committee. The company expressed gratitude for his leadership. Concurrently, Mr. Ravi Moti Kirpalani has been appointed as an Additional Independent Director for a five-year term starting September 1, 2026, subject to shareholder approval. He will also assume the role of Chairman of the Board from September 12, 2026.

Bayer AG, a promoter of Bayer CropScience Limited, has acquired 53,54,030 equity shares from another promoter, Bayer CropScience AG, through a block deal on July 8, 2026. This inter-se transfer among promoters is in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquisition price was Rs. 4,122.30 per share. The necessary disclosures and reports have been submitted to SEBI and the stock exchanges within the stipulated timelines, along with the required fees.

Bayer CropScience Ltd has issued a letter to shareholders whose email addresses are not registered, providing a weblink to access the Annual Report for the Financial Year 2025-26. This action complies with SEBI Listing Regulations, 2015. The Annual Report is available on the company's website, NSDL, and BSE. Shareholders can request physical copies or update their details via email or through the Registrar and Transfer Agent. The 68th AGM is scheduled for August 19, 2026, via VC/OAVM.

Bayer CropScience Ltd has filed its Business Responsibility & Sustainability Report (BRSR) for the Financial Year ended March 31, 2026. This report is an integral part of the company's Annual Report for the same fiscal year. The BRSR details the company's corporate identity, business activities which include crop protection (76% turnover) and hybrid seeds (19% turnover), operational locations, market served, and employee statistics. The company's operations are primarily domestic, serving 25 states and 13 countries internationally, with exports contributing 5% to total turnover. The report also mentions TÜV India Private Limited as the assurance provider for BRSR Core Reasonable Assurance.